Sign inJoin waitlistJoin the waitlist

RS

Richard Shames

Physician · STANFORD HEALTH CARE

Credentials: · ·

History

STANFORD HEALTH CARE
Present

Pediatrics
UC Berkeley – UCSF Joint Medical Program

Research

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
British Journal of Dermatology · 2015 · Last of 13 authors · 227 citations
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial
American Journal of Respiratory and Critical Care Medicine · 2008 · 107 citations
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind,…
Gut · 2006 · Last of 17 authors · 93 citations

EG
Edward Goetzl
4 papers
JK
Jeffrey Kishiyama
4 papers
DA
Daniel Adelman
3 papers
BC
Beth Corn
2 papers
Charlotte Cunningham-Rundles
2 papers
DU
Dale Umetsu
2 papers
David Bergman
2 papers
KS
Kirk Sperber
2 papers
Paul Sharek
2 papers
Stuart Abramson
2 papers
William Sandborn
2 papers
WS
William Shearer
2 papers